Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Polygenic risk score and lipoprotein(a) in relation to low-density lipoprotein cholesterol levels in Czech newborn cohort

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F25%3A00142078" target="_blank" >RIV/00216224:14110/25:00142078 - isvavai.cz</a>

  • Výsledek na webu

  • DOI - Digital Object Identifier

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Polygenic risk score and lipoprotein(a) in relation to low-density lipoprotein cholesterol levels in Czech newborn cohort

  • Popis výsledku v původním jazyce

    Elevated low-density lipoprotein cholesterol (LDL-C) levels in childhood is a major risk factor for premature cardiovascular disease (CVD). While monogenic familial hypercholesterolemia is well recognized, a significant proportion of patients with elevated LDL-C levels have polygenic cause of their condition. Polygenic risk score (PRS) that aggregates the impact of multiple common variants associated with LDL-C levels is commonly used to characterise polygenic hypercholesterolemia. Lipoprotein(a) (Lp(a)), an LDL-like particle containing apolipoprotein(a), represents additional CVD risk. Lp(a) levels are predominantly determined by genetic factors. Elevated Lp(a) can contribute to measured LDL-C and potentially confound its interpretation. In this study, we analysed umbilical cord blood samples from pilot newborn screening project. For nearly 6000 newborns, the LDL-C levels were measured at study enrolment and LDL-C level percentiles were ascertained. For individuals with low (0-15th percentile), medium (40-60th percentile) and high (75-100th percentile) LDL-C levels, we analysed the PRS and Lp(a) values. PRS and Lp(a) were assessed as independent genetic risk factors for elevated LDL-C. Preliminary results show statistically significant differences in PRS and Lp(a) levels between groups with low, medium, and high LDL-C. Results indicate that evaluation of PRS and Lp(a) measurement are important, as both may contribute to explaining elevated LDL-C levels in individuals with hypercholesterolemia.

  • Název v anglickém jazyce

    Polygenic risk score and lipoprotein(a) in relation to low-density lipoprotein cholesterol levels in Czech newborn cohort

  • Popis výsledku anglicky

    Elevated low-density lipoprotein cholesterol (LDL-C) levels in childhood is a major risk factor for premature cardiovascular disease (CVD). While monogenic familial hypercholesterolemia is well recognized, a significant proportion of patients with elevated LDL-C levels have polygenic cause of their condition. Polygenic risk score (PRS) that aggregates the impact of multiple common variants associated with LDL-C levels is commonly used to characterise polygenic hypercholesterolemia. Lipoprotein(a) (Lp(a)), an LDL-like particle containing apolipoprotein(a), represents additional CVD risk. Lp(a) levels are predominantly determined by genetic factors. Elevated Lp(a) can contribute to measured LDL-C and potentially confound its interpretation. In this study, we analysed umbilical cord blood samples from pilot newborn screening project. For nearly 6000 newborns, the LDL-C levels were measured at study enrolment and LDL-C level percentiles were ascertained. For individuals with low (0-15th percentile), medium (40-60th percentile) and high (75-100th percentile) LDL-C levels, we analysed the PRS and Lp(a) values. PRS and Lp(a) were assessed as independent genetic risk factors for elevated LDL-C. Preliminary results show statistically significant differences in PRS and Lp(a) levels between groups with low, medium, and high LDL-C. Results indicate that evaluation of PRS and Lp(a) measurement are important, as both may contribute to explaining elevated LDL-C levels in individuals with hypercholesterolemia.

Klasifikace

  • Druh

    O - Ostatní výsledky

  • CEP obor

  • OECD FORD obor

    10603 - Genetics and heredity (medical genetics to be 3)

Návaznosti výsledku

  • Projekt

    <a href="/cs/project/LX22NPO5104" target="_blank" >LX22NPO5104: Národní institut pro výzkum metabolických a kardiovaskulárních onemocnění</a><br>

  • Návaznosti

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach

Ostatní

  • Rok uplatnění

    2025

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů